DA
GRTS

Denali Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Denali Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,600
Closed -$19K – 427
2022
Q1 		$19K Hold
4,600
– – 0.01% 316
2021
Q4 		$59K Buy
+4,600
New +$50.9K 0.02% 233

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Denali Advisors's GRTS Position: Q2 2022 in Review

Denali Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2022, closing a stake of 4,600 shares — an estimated $19K sold.

Denali Advisors first reported a position in GRTS in Q4 2021 and held it in 2 quarters. The position peaked at $59K in Q4 2021. 87 funds tracked by Wall St. Rank hold GRTS as of Q2 2022.

  • Denali Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Denali Advisors sold 4,600 Gritstone bio, Inc. Common Stock shares in Q2 2022, an estimated $19K.
  • Denali Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Denali Advisors's Gritstone bio, Inc. Common Stock position peaked at $59K in Q4 2021.
  • 87 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2022.

Based on Denali Advisors's 13F filing for Q2 2022, filed 18 Jul 2022.